Associated Papers
Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F et al.
Cancers, 2022
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling.
Zhang Y et al.
Frontiers in Oncology, 2022
TIM3 comes of age as an inhibitory receptor.
Wolf Y et al.
Nature Reviews. Immunology, 2020
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden T et al.
Nature Genetics, 2018
Select a paper to view details